JPS vt-x7 treatment.jpg

Pipeline Overview​

Pipeline Overview​

  • Company

    • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Investors
    • Intellectual Property
  • About Joint Infection

  • Pipeline

    • Pipeline Overview
    • VT-X7
    • Clinical Trials
  • APEX Clinical Study

  • News and Events

  • Careers

  • Contact

  • More

    Use tab to navigate through the menu items.

    News

    3/8/22

    Osteal Therapeutics Closes an Oversubscribed $30 Million Series B Financing to Advance Platform Therapyfor Treatment of Musculoskeletal Infection
    Learn More

    1/7/21

    JPS is now Osteal Therapeutics®

    ​

    Learn More
    • LinkedIn
    • Facebook
    • Twitter
    About Joint Infection
    Pipeline
    Pipeline Overview
    VT-X7
    Clinical Trials
    Home
    Company
    About Us
    Leadership
    Board of Directors
    Scientific Advisors
    Investors
    Intellectual Property
    News and Events
    Contact

    Privacy Policy

    © 2022  Osteal Therapeutics®.